Log in to save to my catalogue

Bedtime Single-Dose Prednisolone in Clinically Stable Rheumatoid Arthritis Patients

Bedtime Single-Dose Prednisolone in Clinically Stable Rheumatoid Arthritis Patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3316977

Bedtime Single-Dose Prednisolone in Clinically Stable Rheumatoid Arthritis Patients

About this item

Full title

Bedtime Single-Dose Prednisolone in Clinically Stable Rheumatoid Arthritis Patients

Publisher

Cairo, Egypt: Hindawi Puplishing Corporation

Journal title

ISRN pharmacology, 2012, Vol.2012 (2012), p.1-5

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Puplishing Corporation

More information

Scope and Contents

Contents

Introduction. Sign and symptoms of rheumatoid arthritis have circadian rhythms and are more prominent in the morning. Timing of glucocorticoid administration may be important with respect to the natural secretion of endogenous glucocorticoids. Herein, we intended to test the hypothesis that bedtime administration of prednisolone could be more effic...

Alternative Titles

Full title

Bedtime Single-Dose Prednisolone in Clinically Stable Rheumatoid Arthritis Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3316977

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3316977

Other Identifiers

ISSN

2090-5165,2090-5173

E-ISSN

2090-5173

DOI

10.5402/2012/637204

How to access this item